Imperva (IMPV) Downgraded to “Underweight” at J P Morgan Chase & Co

J P Morgan Chase & Co lowered shares of Imperva (NASDAQ:IMPV) from a neutral rating to an underweight rating in a report issued on Tuesday. The brokerage currently has $45.00 target price on the software maker’s stock.

IMPV has been the subject of several other reports. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a research note on Tuesday, August 22nd. Zacks Investment Research upgraded shares of Imperva from a hold rating to a strong-buy rating and set a $50.00 price objective for the company in a research note on Tuesday, October 24th. Morgan Stanley reiterated an underweight rating and set a $39.00 price objective on shares of Imperva in a research note on Thursday, November 9th. Wells Fargo & Company downgraded shares of Imperva from an outperform rating to a market perform rating in a research note on Monday, October 9th. Finally, Piper Jaffray Companies set a $58.00 price objective on shares of Imperva and gave the stock a buy rating in a research note on Monday, August 28th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of Hold and a consensus target price of $51.86.

Imperva (NASDAQ IMPV) traded down $1.50 on Tuesday, reaching $40.35. 475,300 shares of the company’s stock traded hands, compared to its average volume of 431,456. Imperva has a 12 month low of $35.80 and a 12 month high of $52.40.

Imperva (NASDAQ:IMPV) last released its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. During the same period in the previous year, the firm earned $0.08 earnings per share. Imperva’s revenue for the quarter was up 22.6% on a year-over-year basis. sell-side analysts predict that Imperva will post -0.52 EPS for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Van ECK Associates Corp boosted its stake in Imperva by 0.8% during the 2nd quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock valued at $399,000 after acquiring an additional 64 shares during the last quarter. Comerica Bank boosted its stake in Imperva by 0.8% during the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock valued at $978,000 after acquiring an additional 157 shares during the last quarter. Ameritas Investment Partners Inc. boosted its stake in Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after acquiring an additional 464 shares during the last quarter. Aperio Group LLC boosted its stake in Imperva by 8.1% during the 2nd quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock valued at $340,000 after acquiring an additional 531 shares during the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in Imperva by 5.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock valued at $556,000 after acquiring an additional 581 shares during the last quarter. Hedge funds and other institutional investors own 96.95% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/12/13/imperva-impv-downgraded-to-underweight-at-j-p-morgan-chase-co.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply